Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jul 8:2010:610613.
doi: 10.4061/2010/610613.

Lessons from Multicenter Studies on CSF Biomarkers for Alzheimer's Disease

Niklas Mattsson  1 , Henrik Zetterberg, Kaj Blennow
Affiliations

Lessons from Multicenter Studies on CSF Biomarkers for Alzheimer's Disease

Niklas Mattsson et al. Int J Alzheimers Dis. .

Abstract

Several single-center studies have confirmed the usability of cerebrospinal fluid (CSF) biomarkers for the diagnosis of Alzheimer's disease (AD), even in early disease stages. Large scale multicenter studies have principally confirmed this, although such studies have also indicated the presence of significant intercenter and interlaboratory variations in biomarker measurements. Such variations may hamper the development of biomarkers and their introduction into clinical routine practice. Recently a quality control program run by the Alzheimer's Association was started in order to harmonize procedures of laboratories world-wide. This program provides both standardized guide lines and external control CSF samples, and will allow longitudinal evaluation of laboratory performance.

PubMed Disclaimer

References

    1. Blennow K, Hampel H, Weiner M, Zetterberg H. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nature Reviews Neurology. 2010;6(3):131–144. - PubMed
    1. Frisoni GB, et al. The clinical use of structural MRI in Alzheimer disease. Nature Reviews Neurology. 2010;6(2):67–77. - PMC - PubMed
    1. Nordberg A, Rinne JO, Kadir A, Lngström B. The use of PET in Alzheimer disease. Nature Reviews Neurology. 2010;6(2):78–87. - PubMed
    1. Strozyk D, Blennow K, White LR, Launer LJ. CSF Aß 42 levels correlate with amyloid-neuropathology in a population-based autopsy study. Neurology. 2003;60(4):652–656. - PubMed
    1. Tapiola T, Alafuzoff I, Herukka S-K, et al. Cerebrospinal fluid β-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Archives of Neurology. 2009;66(3):382–389. - PubMed

LinkOut - more resources